Has Osama Hlalah received payments from drug or device companies?

Yes. Drug and device makers reported $411,033 in general payments to Osama Hlalah across 515 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Osama Hlalah did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Osama Hlalah come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Osama Hlalah

Hematology & Oncology · Gainesville, FLNPI 1144210022

Payments from drug & device makers

$411,033in general payments, 2019–2025

Across 515 payments — averaging $798.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$251K
Incyte Corporation$53K
Helsinn Healthcare SA$26K
Amgen$24K
AMAG Pharmaceuticals, Inc.$21K
Bristol Myers Squibb$11K
plus $24K from 48 others

What the payments were for

Consulting fees$7,71519%
Speaking & faculty fees$21,00052%
Travel & lodging$2,7987%
Food & beverage$6,75517%
Education$3371%
Other$1,5314%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	10	$251,407
Incyte Corporation	102	$53,295
Helsinn Healthcare SA	7	$25,799
Amgen	12	$24,348
AMAG Pharmaceuticals, Inc.	24	$20,954
Bristol Myers Squibb	22	$11,016
Spectrum Pharmaceuticals Inc.	4	$5,472
Johnson & Johnson(2 entities)	28	$5,085
E.r. Squibb & Sons, L.L.C.	37	$4,340
Rigel Pharmaceuticals, Inc.	6	$2,992
Novartis	58	$2,325
Astellas Pharma US Inc	26	$522
Pfizer	31	$439
Merck	18	$352
Daiichi Sankyo Inc.	15	$306
Sanofi	9	$189
Boehringer Ingelheim	7	$164
Seagen Inc.	4	$152
Genentech USA, Inc.	8	$149
Gilead(2 entities)	8	$145
Exelixis Inc.	7	$114
Lilly USA, LLC	7	$105
Array Biopharma Inc	6	$105
Takeda Pharmaceuticals U.S.A., Inc.	4	$91
Coherus Oncology, Inc.	2	$91
Jazz Pharmaceuticals Inc.	5	$88
Eisai Inc.	5	$88
Global Blood Therapeutics, Inc.	4	$77
US Oncology Corporate, Inc.	1	$69
AbbVie	3	$63
Pharmacyclics LLC, An Abbvie Company	2	$58
Foundation Medicine, Inc.	2	$57
Bayer	3	$56
Karyopharm Therapeutics Inc.	3	$49
Acceleron Pharma, Inc.	3	$48
Clovis Oncology, Inc.	3	$47
Genmab U.S., Inc.	1	$32
Morphosys, US Inc.	2	$31
Tersera Therapeutics LLC	1	$25
Mirati Therapeutics, Inc.	1	$23
Ipsen Biopharmaceuticals, Inc	1	$23
Mylan Institutional Inc.	1	$22
Emmaus Medical, Inc.	1	$22
Abbott	1	$22
Partner Therapeutics, Inc.	1	$20
Taiho Oncology, Inc.	1	$19
Sobi, Inc	1	$19
CTI Biopharma Corp.	1	$19
GSK	1	$18
Dova Pharmaceuticals	1	$17
Pharmacosmos Therapeutics Inc.	1	$17
Myovant Sciences Inc.	1	$16
Tactile Systems Technology Inc	1	$15
Verastem, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FERAHEME$20,629
IMBRUVICA$4,575
Revlimid$3,526
Tavalisse$2,892
MEKINIST$101
TAFINLAR$101

How this compares

$411,033 in reported general payments places this provider in the 75th percentile of 694 hematology & oncology providers in Florida.

See all hematology & oncology providers in Florida →

Other hematology & oncology in Gainesville

Thomas GeorgeGainesville$10.3M
Carl LandgrenMiami$47.8M
Julio ChavezTampa$16.4M
Steven AttiaJacksonville$13.9M
Santosh NairOrange City$13.5M
Frederick LockeTampa$12.8M
Tarek MekhailOrlando$11.2M
Carlos AlemanyOrlando$10.9M
Sikander AilawadhiJacksonville$9.8M
Richard KimTampa$8.5M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →